Diazepam-IV
Level |
Direction |
Primary Outcome |
Patient/Process |
Setting |
Reference |
I
|
Supportive (Green)
|
Termination of seizure by Ed arrival
|
Patient
|
PH-Paramedic
|
Alldredge BK., Gelb AM., Isaacs SM., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345(9):631-7. Medline
|
I
|
Supportive (Green)
|
Seizure cessation
|
Patient
|
PH-Paramedic
|
Cruickshank M, Imamura M, Booth C, Aucott L, Counsell C, Manson P, et al. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis. Heal Technol Assess 2022; 26(20):1–76. Medline
|
I
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
In-Patient
|
Treiman DM., Meyers PD., Walton NY., et al. A comparison of four treatments for generalized convulsive status epilepticus. New Eng J Med 1998; 339(12):793-798. Medline
|
I
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
|
Wu W., Zhang L., Xue R. Lorazepam or diazepam for convulsive status epilepticus: A meta-analysis. J Clin Neurosci 2016; 29:133-138. Medline
|
II
|
Supportive (Green)
|
Time to seizure termination
|
Patient
|
PH-Paramedic
|
Haut SR., Seinfeld S., Pellock J. Benzodiazepine use in seizure emergencies: A systematic review. Epilepsy Behav 2016; 63:109-17. Medline
|
Lorazepam-IV
Level |
Direction |
Primary Outcome |
Patient/Process |
Setting |
Reference |
I
|
Supportive (Green)
|
Termination of seizure by ED arrival
|
Patient
|
PH-Paramedic
|
Alldredge BK., Gelb AM., Isaacs SM., et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345(9):631-7. Medline
|
I
|
Supportive (Green)
|
Seizure cessation
|
Patient
|
PH-Paramedic
|
Cruickshank M, Imamura M, Booth C, Aucott L, Counsell C, Manson P, et al. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis. Heal Technol Assess 2022; 26(20):1–76. Medline
|
I
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
PH-Paramedic
|
Silbergleit R., Durkalski V., Lowenstein D., Conwit R., Pancioli A., Palesch Y., et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366(7):591-600. Medline
|
I
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
In-Patient
|
Treiman DM., Meyers PD., Walton NY., et al. A comparison of four treatments for generalized convulsive status epilepticus. New Eng J Med 1998; 339(12):793-798. Medline
|
I
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
|
Wu W., Zhang L., Xue R. Lorazepam or diazepam for convulsive status epilepticus: A meta-analysis. J Clin Neurosci 2016; 29:133-138. Medline
|
II
|
Neutral (Yellow)
|
Time to administration
|
Process
|
PH-Paramedic
|
Fitzgerald BJ., Okos AJ., Miller JW. Treatment of out-of-hospital status epilepticus with diazepam rectal gel. Seizure 2003; 12(1):52-5. Medline
|
Midazolam-IM
Level |
Direction |
Primary Outcome |
Patient/Process |
Setting |
Reference |
I
|
Supportive (Green)
|
Seizure cessation
|
Patient
|
PH-Paramedic
|
Cruickshank M, Imamura M, Booth C, Aucott L, Counsell C, Manson P, et al. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis. Heal Technol Assess 2022; 26(20):1–76. Medline
|
I
|
Supportive (Green)
|
termination of seizure
|
Patient
|
PH-Paramedic
|
Silbergleit R., Durkalski V., Lowenstein D., Conwit R., Pancioli A., Palesch Y., et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366(7):591-600. Medline
|
II
|
Supportive (Green)
|
Need for repeat Midazolam dose
|
Patient
|
PH-Paramedic
|
Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology 2020; 95(24):e3203-12. Medline
|
II
|
Supportive (Green)
|
Reduced mortality & LOS from earlier treatment of status epilepticus.
|
Patient
|
PH-Paramedic
|
Halliday AJ, Santamaria J, D’Souza WJ. Pre-hospital benzodiazepines associated with improved outcomes in out-of-hospital status epilepticus: A 10-year retrospective cohort study. Epilepsy Res 2021; 179:106846. Medline
|
II
|
Supportive (Green)
|
Length of stay (LOS)
|
Patient
|
ICU
|
Rao SK, Mahulikar A, Ibrahim M, Shah A, Seraji-Bozorgzad N, Mohamed W. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic disorders, international epilepsy J with videotape 2018; 20(4) 265-9. Medline
|
X
|
Not Yet Graded (White)
|
-
|
|
|
Fouche PF, Nichols M, Abrahams R, Maximous K, Bendall J. Evaluating the effectiveness of the maximum permitted dose of midazolam in seizure termination: Insights from New South Wales, Australia. Emerg Med Australas June 2024. Medline
|
Midazolam-IN
Level |
Direction |
Primary Outcome |
Patient/Process |
Setting |
Reference |
II
|
Neutral (Yellow)
|
treatment with a second
benzodiazepine dose
|
Patient
|
PH-Paramedic
|
Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology 2020; 95(24):e3203-12. Medline
|
III
|
Supportive (Green)
|
Seizure suppression
|
Patient
|
In-Patient
|
de Haan GJ., van der Geest P., Doelman G., Bertram E., Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia 2010; 51(3):478-82. Medline
|
III
|
Supportive (Green)
|
Termination of seizure
|
Patient
|
ED-MD
|
Kendall JL., Reynolds M., Goldberg R. Intranasal midazolam in patients with status epilepticus. Ann Emerg Med 1997; 29(3):415-7. Medline
|
III
|
Neutral (Yellow)
|
Need for second dose
|
Patient
|
PH-Paramedic
|
Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology 2020; 95(24):e3203-12. Medline
|
Midazolam-IV
Level |
Direction |
Primary Outcome |
Patient/Process |
Setting |
Reference |
II
|
Supportive (Green)
|
seizure duration and hospital length of stay
|
Patient
|
PH-Paramedic
|
Halliday AJ, Santamaria J, D’Souza WJ. Pre-hospital benzodiazepines associated with improved outcomes in out-of-hospital status epilepticus: A 10-year retrospective cohort study. Epilepsy Res 2021; 179:106846. Medline
|
II
|
Supportive (Green)
|
Length of stay
|
Patient
|
ICU
|
Rao SK, Mahulikar A, Ibrahim M, Shah A, Seraji-Bozorgzad N, Mohamed W. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus. Epileptic disorders, international epilepsy J with videotape 2018; 20(4) 265-9. Medline
|
III
|
Supportive (Green)
|
Supportive
|
Patient
|
PH-Paramedic
|
Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology 2020; 95(24):e3203-12. Medline
|
III
|
Neutral (Yellow)
|
Requirement for second dose
|
Patient
|
PH-Paramedic
|
Guterman EL, Sanford JK, Betjemann JP, Zhang L, Burke JF, Lowenstein DH, et al. Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus. Neurology 2020; 95(24):e3203-12. Medline
|
X
|
Not Yet Graded (White)
|
-
|
|
|
Fouche PF, Nichols M, Abrahams R, Maximous K, Bendall J. Evaluating the effectiveness of the maximum permitted dose of midazolam in seizure termination: Insights from New South Wales, Australia. Emerg Med Australas June 2024. Medline
|